FDA Rejects New Use For J&J Immune Disorder Drug

RA Guy Community News

Healthcare giant Johnson & Johnson plans to meet with U.S. regulators after they refused to approve a new use for the company’s immune disorder drug, Simponi.

The company, based in New Brunswick, N.J., said Friday night that the Food and Drug Administration notified its Janssen Biotech Inc. subsidiary that it would not approve marketing of Simponi for limiting progression of structural damage in patients with moderate to severe rheumatoid arthritis.

Read More: http://www.businessweek.com/ap/financialnews…